First Page | Document Content | |
---|---|---|
Health Jeffrey Shuren Center for Drug Evaluation and Research Center for Devices and Radiological Health Food and Drug Administration Pharmaceutical sciences Clinical research | U.S. Food and Drug Administration Office of Health and Constituent Affairs (OHCA) White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Section A), Silver Spring MD[removed]Thursday, OctobAdd to Reading ListSource URL: www.fda.gov.Download Document from Source WebsiteFile Size: 49,91 KBShare Document on Facebook |
CENTER FOR DRUG EVALUATION AND RESEARCH DRUG SAFETY PRIORITIES 2017DocID: 1ueGS - View Document | |
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 208573Orig1s000 SUMMARY REVIEWDocID: 1t19G - View Document | |
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022526Orig1s000 SUMMARY REVIEWDocID: 1sZi5 - View Document | |
MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHDocID: 1sPXO - View Document | |
Abstract # 2639 Enhanced (Q)SAR Models for Prediction Rodent Carcinogenicity Naomi L. Kruhlak1, Dongyu Guo1, Kevin P. Cross2, Lidiya Stavitskaya1 FDA Center for Drug Evaluation and Research (CDER), 10903 New Hampshire ADocID: 1swgc - View Document |